Fundraising Fox

Toku

9 known investors

tokueyes.com ↗

Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

MV
Michael V. McConnellinChief Health Officer and Interim CEO
FL
Francesca LoganinChief Commercial Officer
YL
Yariv LevininChief Compliance, Ethics and Clinical Affairs Officer

Investors · 9

Arc AngelsAuckland
Icehouse VenturesAuckland · $120K – $2.4M
Outset VenturesAuckland · $100K – $10Mvia Mat Rowe · inferred
gmjpreportedWellesley
Gradient VenturesreportedSan Francisco · $100K – $10M
Next Web CapitalreportedTokyo
Oak HC/FTreportedStamford
Quantstampreported
ReveriereportedNew York

In the news

Toku Delivers 13% Revenue Growth in 1H2026, Backed by Strengthened Balance Sheet and Commercial Executionprnewswire.com · Jul 2026Toku lands $48m Series A to expand recurring payment solutionsfintechfutures.com · Apr 2025Toku Raises $48 Million Series Abusinesswire.com · Apr 2025Toku secures $9.3 million in latest funding round led by Gradientprnewswire.com · Apr 2024Toku Raises $9.3M in Fundingfinsmes.com · Apr 2024Crypto payroll startup Toku raises $20 million | Fortunefortune.com · Mar 2023

Frequently asked questions

What does Toku do?
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
Who are Toku's investors?
Toku's investors include Arc Angels, Icehouse Ventures, Outset Ventures, gmjp, Gradient Ventures, Next Web Capital, Oak HC/FT, Quantstamp and 1 more.